These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24878110)

  • 1. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.
    Trauer JM; Denholm JT; McBryde ES
    J Theor Biol; 2014 Oct; 358():74-84. PubMed ID: 24878110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of tuberculosis burden in China using a dynamic disease simulation model.
    Mehra M; Cossrow N; Kambili C; Underwood R; Makkar R; Potluri R
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1186-94. PubMed ID: 23827732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.
    Schluger NW; El-Bassel N; Hermosilla S; Terlikbayeva A; Darisheva M; Aifah A; Galea S
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S32-6. PubMed ID: 23928052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the transmission risk of multidrug-resistant Mycobacterium tuberculosis epidemics in regions of Taiwan.
    Liao CM; Lin YJ
    Int J Infect Dis; 2012 Oct; 16(10):e739-47. PubMed ID: 22818291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
    Leimane V; Leimans J
    Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDR-TB--its characteristics and control in Asia-Pacific rim symposium in USJCMSP 10th international conference on emerging infectious diseases in the Pacific rim.
    Mori T
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S5-9. PubMed ID: 17588496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why the tuberculosis incidence rate is not falling in New Zealand.
    Das D; Baker M; Venugopal K; McAllister S
    N Z Med J; 2006 Oct; 119(1243):U2248. PubMed ID: 17063188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis.
    Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES
    BMC Infect Dis; 2017 May; 17(1):374. PubMed ID: 28558651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for advancing tuberculosis control efforts through novel therapies.
    Salomon JA; Lloyd-Smith JO; Getz WM; Resch S; Sánchez MS; Porco TC; Borgdorff MW
    PLoS Med; 2006 Aug; 3(8):e273. PubMed ID: 16866578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis problems in the Asia-Pacific region.
    Shimouchi A
    Respirology; 2001 Mar; 6(1):75-8. PubMed ID: 11264768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.